Advertisement
News
Advertisement

Keeping Ahead in China Means Adapting to a Shifting Market, Analysts Say

Mon, 04/01/2013 - 3:14pm
Mass Device

Analysts at PricewaterhouseCoopers say that life sciences companies that are ready to evolve along with China's shifting landscape will be in the best position to capitalize on what's projected to become a $1 trillion healthcare market within the decade.

China with flag overlay

Many medical device companies have their eye on China - and with good reason - but the country's approach to healthcare is shifting, and companies that hope to capitalize on the China's exponential growth must be prepared to change with it, according to analysts at PricewaterhouseCoopers.

China's healthcare market is an irresistibly attractive one, given recent spikes in healthcare spending and more surges projected down the line, but "the rules to succeed in China's new economy are changing, and companies that are able to adapt may be well positioned to realize the benefits of participating in this important market," PwC researchers said.

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading